Literature DB >> 16413451

An independent AGREE evaluation of the Occupational Medicine Practice Guidelines.

Jeffrey R Cates1, David N Young, Daniel S Bowerman, Robert C Porter.   

Abstract

BACKGROUND AND CONTEXT: A large number of practice guidelines are being produced by numerous organizations. Health-care professionals need to critically evaluate these practice guidelines to understand whether they are well constructed and representative of the preponderance of evidence. The guideline development process should be precise and rigorous to ensure that the results are reproducible and not vague.
PURPOSE: To evaluate the quality of the second edition of the practice guidelines published by the American College of Occupational and Environmental Medicine (ACOEM Guidelines). STUDY DESIGN/
SETTING: Four appraisers used the AGREE (Appraisal of Guidelines Research and Evaluation) guideline evaluation instrument to evaluate the ACOEM Guidelines.
METHODS: The Guidelines were evaluated with the AGREE guideline evaluation instrument. The AGREE instrument has been widely adopted around the world, and the authors recommended that it be adopted as the standard of guideline construction process evaluation in the United States. The instrument standardizes the quantitative assessment of quality for a guideline's development process across six domains that include: scope and purpose, stakeholder involvement, rigor of development, clarity and presentation, application, and editorial independence. Scores from four assessors were collected and interpreted. Additionally, each evaluator selected one of four global assessment choices: "strongly recommended for use in practice," "recommended for use with some modification or proviso," "not recommended as suitable for use in practice," or "unsure".
RESULTS: The ACOEM Guidelines scored highest in the dimensions that evaluated reporting of the guideline's scope and purpose (79.63) as well as clarity and presentation (86.81). The guideline scored much lower in the remaining areas that included stakeholder involvement (46.06), rigor of development (26.59), application (31.48), and editorial independence (19.17). The global assessment was unanimous with all four evaluators assessing the guideline as recommend with proviso.
CONCLUSIONS: Many of the Guidelines recommendations were consistent with current literature and guidelines; however, the AGREE assessment instrument evaluates the guideline development process and not the content. All the evaluators thought the content of the guidelines was substantially better than the documentation of the guideline construction process. The ACOEM Guidelines appear to have content consistent with their stated objectives, but the reporting of the guidelines construction process, particularly the rigor of recommendation development, is flawed, and the recommendations may not be valid owing to possible evidence selection deficiencies. The reader should consider these flaws and limitations when using the guideline. The reader should consider utilizing guidelines of higher quality when possible. Future guidelines should incorporate better reporting and give closer attention to guideline construction.

Mesh:

Year:  2006        PMID: 16413451     DOI: 10.1016/j.spinee.2005.06.012

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  11 in total

1.  The Quality of Six Clinical Practice Guidelines in Health and Social Sciences: Are We on the Right Track?

Authors:  Catherine Hébert; Kia Watkins-Martin; Gabrielle Ciquier; Michelle Azzi; Martin Drapeau
Journal:  Adm Policy Ment Health       Date:  2021-04-18

Review 2.  A critical appraisal of the quality of critical care pharmacotherapy clinical practice guidelines and their strength of recommendations.

Authors:  Sean K Gorman; Michelle Ho Chung; Richard S Slavik; Peter J Zed; Kerry Wilbur; Vinay K Dhingra
Journal:  Intensive Care Med       Date:  2010-03-09       Impact factor: 17.440

Review 3.  Neck pain clinical practice guidelines: a systematic review of the quality and quantity of complementary and alternative medicine recommendations.

Authors:  Jeremy Y Ng; Mitali Uppal; Jeremy Steen
Journal:  Eur Spine J       Date:  2022-07-23       Impact factor: 2.721

4.  Critical appraisal of clinical practice guidelines in pediatric infectious diseases.

Authors:  Kyle John Wilby; Emily Kathleen Black; Claire MacLeod; Matthew Wiens; Tim T Y Lau; Maria A Paiva; Sean Gorman
Journal:  Int J Clin Pharm       Date:  2015-04-25

Review 5.  Employer Best Practice Guidelines for the Return to Work of Workers on Mental Disorder-Related Disability Leave: A Systematic Review.

Authors:  Carolyn S Dewa; Lucy Trojanowski; Margot C W Joosen; Sarah Bonato
Journal:  Can J Psychiatry       Date:  2016-02-10       Impact factor: 4.356

6.  Analysis of the status of Chinese clinical practice guidelines development.

Authors:  Zhi-hong Zheng; Shu-qi Cui; Xiao-qin Lu; David Zakus; Wan-nian Liang; Fang Huang; Xiao-na Cao; Ya-li Zhao; Xiao-xia Peng; Ke-qin Rao; Jing Wu
Journal:  BMC Health Serv Res       Date:  2012-07-25       Impact factor: 2.655

7.  Maternal and perinatal guideline development in hospitals in South East Asia: results from the SEA-ORCHID project.

Authors:  Jadsada Thinkhamrop; Tari Turner; Sivasangari Subramaniam
Journal:  Health Res Policy Syst       Date:  2009-05-08

8.  Evidence-based guidelines in the evaluation of work disability: an international survey and a comparison of quality of development.

Authors:  Wout El de Boer; David J Bruinvels; Arie M Rijkenberg; Peter Donceel; Johannes R Anema
Journal:  BMC Public Health       Date:  2009-09-18       Impact factor: 3.295

9.  Developing evidence-based clinical practice guidelines in hospitals in Australia, Indonesia, Malaysia, the Philippines and Thailand: values, requirements and barriers.

Authors:  Tari J Turner
Journal:  BMC Health Serv Res       Date:  2009-12-15       Impact factor: 2.655

10.  Development of evidence-based clinical practice guidelines (CPGs): comparing approaches.

Authors:  Tari Turner; Marie Misso; Claire Harris; Sally Green
Journal:  Implement Sci       Date:  2008-10-27       Impact factor: 7.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.